A detailed history of Nomura Asset Management CO LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 866,970 shares of GILD stock, worth $79.2 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
866,970
Previous 964,625 10.12%
Holding current value
$79.2 Million
Previous $66.2 Million 9.8%
% of portfolio
0.23%
Previous 0.23%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$66.59 - $83.99 $6.5 Million - $8.2 Million
-97,655 Reduced 10.12%
866,970 $72.7 Million
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $3.77 Million - $4.36 Million
59,774 Added 6.61%
964,625 $66.2 Million
Q1 2024

May 13, 2024

SELL
$71.58 - $87.29 $130,204 - $158,780
-1,819 Reduced 0.2%
904,851 $66.3 Million
Q4 2023

Feb 09, 2024

BUY
$73.27 - $83.09 $1.07 Million - $1.21 Million
14,557 Added 1.63%
906,670 $73.4 Million
Q3 2023

Nov 03, 2023

BUY
$73.94 - $80.67 $2.29 Million - $2.5 Million
31,032 Added 3.6%
892,113 $66.9 Million
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $9.29 Million - $10.6 Million
122,270 Added 16.55%
861,081 $66.4 Million
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $3.84 Million - $4.38 Million
49,701 Added 7.21%
738,811 $61.3 Million
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $5.49 Million - $7.88 Million
-88,068 Reduced 11.33%
689,110 $59.2 Million
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $1.43 Million - $1.63 Million
24,032 Added 3.19%
777,178 $47.9 Million
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $1.65 Million - $1.85 Million
-28,520 Reduced 3.65%
753,146 $46.6 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $3.86 Million - $4.84 Million
66,653 Added 9.32%
781,666 $46.5 Million
Q4 2021

Feb 01, 2022

SELL
$64.88 - $73.64 $12.2 Million - $13.9 Million
-188,800 Reduced 20.89%
715,013 $51.9 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $11.6 Million - $12.5 Million
171,110 Added 23.35%
903,813 $63.1 Million
Q2 2021

Aug 06, 2021

SELL
$63.47 - $69.35 $629,876 - $688,229
-9,924 Reduced 1.34%
732,703 $50.5 Million
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $192,180 - $219,277
-3,203 Reduced 0.43%
742,627 $48 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $11.4 Million - $13 Million
201,921 Added 37.12%
745,830 $43.5 Million
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $7.3 Million - $9.17 Million
117,485 Added 27.55%
543,909 $34.4 Million
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $2.79 Million - $3.24 Million
-38,545 Reduced 8.29%
426,424 $32.8 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $6.78 Million - $8.68 Million
-108,182 Reduced 18.87%
464,969 $34.8 Million
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $117,324 - $129,053
1,904 Added 0.33%
573,151 $37.2 Million
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $1.46 Million - $1.62 Million
23,419 Added 4.27%
571,247 $36.2 Million
Q2 2019

Aug 13, 2019

SELL
$61.87 - $69.38 $588,940 - $660,428
-9,519 Reduced 1.71%
547,828 $37 Million
Q1 2019

May 10, 2019

BUY
$62.53 - $70.05 $3.32 Million - $3.72 Million
53,172 Added 10.55%
557,347 $36.2 Million
Q4 2018

Feb 12, 2019

BUY
$60.54 - $79.0 $4.8 Million - $6.26 Million
79,286 Added 18.66%
504,175 $31.5 Million
Q3 2018

Nov 07, 2018

SELL
$71.28 - $78.92 $1.02 Million - $1.13 Million
-14,267 Reduced 3.25%
424,889 $32.8 Million
Q2 2018

Aug 03, 2018

SELL
$64.88 - $75.68 $18.3 Million - $21.4 Million
-282,705 Reduced 39.16%
439,156 $31.1 Million
Q1 2018

May 14, 2018

SELL
$72.84 - $88.8 $7.15 Million - $8.72 Million
-98,170 Reduced 11.97%
721,861 $54.4 Million
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $73,213 - $85,942
-1,029 Reduced 0.13%
820,031 $58.7 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $25.4 Million - $30.1 Million
352,683 Added 75.3%
821,060 $66.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
468,377
468,377 $33.2 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.